Fonds de solidarité FTQ acquires 31 pct stake in Jamp Pharma
The Fonds de solidarité FTQ has acquired a 31 percent interest in Jamp Pharma Corp, a Boucherville, Québec-based generic pharmaceutical company. The investment's value was not disclosed. Jamp Pharma specializes in developing, distributing and marketing generic drugs and over-the-counter products. It said the partnership with the Fonds will support new product development and increased growth across Canada and in select international markets. Founded in 1988 as a family-owned company, Jamp Pharma was acquired in 2006 by Louis Pilon, its current president and CEO.






